224 related articles for article (PubMed ID: 11693336)
1. Polyspecificity of antimicrosomal thyroid antibodies in hepatitis C virus-related infection.
Peoc'h K; Dubel L; Chazouillères O; Ocwieja T; Duron F; Poupon R; Johanet C
Am J Gastroenterol; 2001 Oct; 96(10):2978-83. PubMed ID: 11693336
[TBL] [Abstract][Full Text] [Related]
2. Incidence of autoimmune thyroiditis in interferon-alpha treated and untreated patients with chronic hepatitis C virus infection.
Rocco A; Gargano S; Provenzano A; Nardone M; De Sanctis GM; Altavilla N; Chircu LV; Grimaldi F
Neuro Endocrinol Lett; 2001; 22(1):39-44. PubMed ID: 11335878
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of HCV antibodies in autoimmune thyroid disease.
Testa A; Castaldi P; Fant V; Fiore GF; Grieco V; De Rosa A; Pazardjiklian MG; De Rosa G
Eur Rev Med Pharmacol Sci; 2006; 10(4):183-6. PubMed ID: 16910348
[TBL] [Abstract][Full Text] [Related]
4. Latent autoimmune thyroiditis in untreated patients with HCV chronic hepatitis: a case-control study.
Ganne-Carrie N; Medini A; Coderc E; Seror O; Christidis C; Grimbert S; Trinchet JC; Beaugrand M
J Autoimmun; 2000 Mar; 14(2):189-93. PubMed ID: 10677250
[TBL] [Abstract][Full Text] [Related]
5. Islet cell and thyroid antibody prevalence in patients with hepatitis C virus infection: effect of treatment with interferon.
Piquer S; Hernández C; Enriquez J; Ross A; Esteban JI; Genescà J; Bonifacio E; Puig-Domingo M; Simó R
J Lab Clin Med; 2001 Jan; 137(1):38-42. PubMed ID: 11150022
[TBL] [Abstract][Full Text] [Related]
6. Treatment of autoimmune and extra-hepatic manifestations of HCV infection.
Lunel F; Cacoub P
Ann Med Interne (Paris); 2000 Feb; 151(1):58-64. PubMed ID: 10761564
[TBL] [Abstract][Full Text] [Related]
7. Association between human leukocyte antigen (HLA) and interferon- induced thyroid diseases in four patients with HCV-related chronic hepatitis.
Labbadia G; Martocchia A; Mammarella A; Paoletti V; Rocco A; Benvenuto R; Antonella P; Rosaria D; Trabace S; Musca A; Falaschi P
Neuro Endocrinol Lett; 2005 Apr; 26(2):109-12. PubMed ID: 15855880
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of antinuclear and anti-liver-kidney-microsome type-1 antibodies in patients with chronic hepatitis C in China.
Bai L; Feng ZR; Lu HY; Li WG; Yu M; Xu XY
Chin Med J (Engl); 2009 Jan; 122(1):5-9. PubMed ID: 19187609
[TBL] [Abstract][Full Text] [Related]
9. High prevalence of anti-phospholipid antibodies and anti-thyroglobulin antibody in patients with hepatitis C virus infection treated with interferon-alpha.
Matsuda J; Saitoh N; Gotoh M; Gohchi K; Tsukamoto M; Syoji S; Miyake K; Yamanaka M
Am J Gastroenterol; 1995 Jul; 90(7):1138-41. PubMed ID: 7611213
[TBL] [Abstract][Full Text] [Related]
10. Hashimoto's disease during interferon-alpha therapy in a patient with pre-treatment negative anti-thyroid autoantibodies and with the specific genetic susceptibility to the thyroid disease.
Martocchia A; Labbadia G; Paoletti V; Gargano S; Grossi A; Trabace S; Musca A; Falaschi P
Neuro Endocrinol Lett; 2001; 22(1):49-52. PubMed ID: 11335880
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune manifestations during interferon therapy in patients with chronic hepatitis C: the hepatologist's view.
Pellicano R; Smedile A; Peyre S; Astegiano M; Saracco G; Bonardi R; Rizzetto M
Minerva Gastroenterol Dietol; 2005 Mar; 51(1):55-61. PubMed ID: 15756146
[TBL] [Abstract][Full Text] [Related]
12. Thyroid disease in HCV carriers undergoing antiviral therapy with interferon plus ribavirin.
Paraná R; Cruz M; Santos-Jesus R; Ferreira K; Codes L; Cruz T
Braz J Infect Dis; 2000 Dec; 4(6):284-90. PubMed ID: 11136525
[TBL] [Abstract][Full Text] [Related]
13. [Occurrence and significance of autoantibodies in the course of interferon therapy of chronic hepatitis C].
Heller J; Musiolik J; Homrighausen A; Sauerbruch T; Spengler U
Dtsch Med Wochenschr; 1996 Sep; 121(39):1179-83. PubMed ID: 8925742
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of organ- and non-organ-specific autoantibodies on the response to anti-viral treatment of patients with chronic hepatitis C.
Gatselis NK; Georgiadou SP; Koukoulis GK; Tassopoulos N; Zachou K; Liaskos C; Hatzakis A; Dalekos GN
Aliment Pharmacol Ther; 2006 Dec; 24(11-12):1563-73. PubMed ID: 17094775
[TBL] [Abstract][Full Text] [Related]
15. Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon alfa therapy.
Deutsch M; Dourakis S; Manesis EK; Gioustozi A; Hess G; Horsch A; Hadziyannis S
Hepatology; 1997 Jul; 26(1):206-10. PubMed ID: 9214471
[TBL] [Abstract][Full Text] [Related]
16. Thyroid dysfunction in antiviral therapy of chronic hepatitis C.
Dabrowska MM; Panasiuk A; Flisiak R
Hepatogastroenterology; 2010; 57(101):826-31. PubMed ID: 21033237
[TBL] [Abstract][Full Text] [Related]
17. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
Wu CH; Xu XY; Tian GS; Yu YY
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
[TBL] [Abstract][Full Text] [Related]
18. Evolution of hepatitis C virus-specific T cell responses and cytokine production in chronic hepatitis C patients treated with high doses of interferon-alpha.
Alvarado Esquivel C; Elewaut A; Philippé J; Elewaut AE; Desombere I; Maertens G; Leroux-Roels G
Rev Invest Clin; 2002; 54(1):41-50. PubMed ID: 11995406
[TBL] [Abstract][Full Text] [Related]
19. Thyroid function and anti-thyroid autoantibodies in untreated children with vertically acquired chronic hepatitis C virus infection.
Indolfi G; Stagi S; Bartolini E; Salti R; de Martino M; Azzari C; Resti M
Clin Endocrinol (Oxf); 2008 Jan; 68(1):117-21. PubMed ID: 17692107
[TBL] [Abstract][Full Text] [Related]
20. [Thyroid disorders associated with interferon treatment in patients with chronic viral hepatitis or multiple sclerosis].
Diago JI; del Olmo D; Alcázar V; Martínez de Icaya P; Rodríguez E; Martínez Montiel P
Med Clin (Barc); 1999 Jun; 113(2):50-1. PubMed ID: 10425619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
